The Immune and Endocrine Systems in Chronic Non-cancer Patients Treated With Opioids
NCT02277080 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82
Last updated 2023-03-20
Summary
The primary aim is to investigate the dose and time dependent effects of different opioids on the immune and endocrine systems.
The secondary aim is to investigate whether associations between the function of the immune and endocrine systems and opioid use influence cognitive function, pain and quality of life.
Conditions
- Pain
- Opioids
- Immune System
- Endocrine System
- Quality of Life
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Per Sjøgren, Proff. · Rigshospitalet, Denmark
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2021-06-30
- Completion
- 2022-12-28
More Related Trials
-
Opioid Misuse in Patients with Cancer
NCT06489769 ·Status: RECRUITING
-
Cognitive Function and Addiction Under Opioid Tapering
NCT03365817 ·Status: COMPLETED ·Phase: PHASE3
-
Identification of Predictive Markers of the Effects of Opioid Therapy in Patients With Chronic Pain.
NCT03701672 ·Status: UNKNOWN
-
Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy
NCT07188857 ·Status: NOT_YET_RECRUITING
-
Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain
NCT03161795 ·Status: COMPLETED
-
Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain
NCT04838925 ·Status: UNKNOWN ·Phase: NA
-
Impact of a Pharmaceutical Interview at the Initiation of Opioid Treatment for Acute Non-cancer Pain
NCT07049796 ·Status: COMPLETED
-
Brain Response to Pain Control in People With Chronic Pain
NCT01878019 ·Status: COMPLETED
-
Comparison of Standard Opioid Prescription Versus Prescription Guided by Pharmacogenetic Analysis in Patients With Non-cancerous Chronic Pain.
NCT03498014 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
NCT00916890 ·Status: SUSPENDED ·Phase: PHASE4
-
Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin
NCT05929339 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
NCT00647127 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Opioid Immunosuppressive Effects
NCT01881802 ·Status: UNKNOWN
-
Developing a Method to Objectively Measure Opioid Analgesia
NCT03605966 ·Status: ACTIVE_NOT_RECRUITING
-
Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function
NCT02469077 ·Status: COMPLETED ·Phase: NA
-
Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
NCT03947749 ·Status: COMPLETED
-
Oxidative Balance in Opioid Therapy
NCT04227223 ·Status: COMPLETED ·Phase: NA
-
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 ·Status: UNKNOWN ·Phase: NA
-
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
NCT01688583 ·Status: COMPLETED
-
Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
NCT00225797 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Opioids on Experimental Hyperalgesia in Oesophagus, Skin and Muscles
NCT00489684 ·Status: COMPLETED
-
Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
NCT02151513 ·Status: COMPLETED
-
OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models
NCT00271973 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Characteristics of Chronic Pain in Patients With Addiction
NCT05976178 ·Status: COMPLETED
-
A Strategy to Reduce Opioid Drug Prescribing by Clinicians
NCT03809507 ·Status: COMPLETED